UTG INC - Quarter Report: 2019 September (Form 10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

⌧	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2019

□	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____________ to ____________

Commission File No. 0-16867

	UTG, INC.
	(Exact name of registrant as specified in its charter)

Delaware		20-2907892
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

	205 NORTH DEPOT STREET
	STANFORD, KY 40484
	(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: (217) 241-6300

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ⌧ No □

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulations S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ⌧ No □

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer □	Accelerated filer □

Non-accelerated filer □	Smaller reporting company ⌧

	Emerging growth company □

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes □ No ⌧

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.

The number of shares outstanding of the registrant’s common stock as of October 31, 2019 was 3,275,880.

UTG, Inc.

(The “Company”)

TABLE OF CONTENTS

PART I. Financial Information	3
Item 1. Financial Statements	3
Condensed Consolidated Balance Sheets	3
Condensed Consolidated Statements of Operations	4
Condensed Consolidated Statements of Comprehensive Income (Loss)	5
Condensed Consolidated Statements of Shareholders' Equity	6
Condensed Consolidated Statements of Cash Flows	8
Notes to Condensed Consolidated Financial Statements	9
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	18
Item 4. Controls and Procedures	23
PART II. Other Information	23
Item 1. Legal Proceedings	23
Item 1A. Risk Factors	23
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	23
Item 3. Defaults Upon Senior Securities	23
Item 4. Mine Safety Disclosures	23
Item 5. Other Information	23
Item 6. Exhibits	23
Exhibit Index	24
Signatures	24

Part 1. Financial Information.

Item 1. Financial Statements.

UTG, Inc.

Condensed Consolidated Balance Sheets (Unaudited)

	September 30, 2019		December 31, 2018*
ASSETS
Investments:
Investments available for sale:
Fixed maturities, at fair value (amortized cost $163,291,888 and $160,895,869)	$	176,002,451	$	160,960,784
Equity securities, at fair value (cost $32,549,036 and $34,885,107)		76,939,974		67,664,482
Equity securities, at cost		11,289,805		12,118,617
Mortgage loans on real estate at amortized cost		8,526,598		9,069,111
Investment real estate		45,796,423		52,518,577
Notes receivable		27,953,110		23,717,312
Policy loans		8,853,633		9,204,222
Total investments		355,361,994		335,253,105

Cash and cash equivalents		25,728,799		20,150,162
Accrued investment income		1,744,076		2,119,882
Reinsurance receivables:
Future policy benefits		25,741,028		26,117,936
Policy claims and other benefits		3,970,131		4,053,882
Cost of insurance acquired		5,040,297		5,622,227
Property and equipment, net of accumulated depreciation		447,905		688,567
Income tax receivable		200,595		279,333
Other assets		636,478		1,263,242
Total assets	$	418,871,303	$	395,548,336

LIABILITIES AND SHAREHOLDERS' EQUITY
Liabilities:
Policy liabilities and accruals:
Future policyholder benefits	$	250,008,948	$	253,852,368
Policy claims and benefits payable		3,769,383		4,267,481
Other policyholder funds		407,283		372,072
Dividend and endowment accumulations		14,649,215		14,608,838
Deferred income taxes		14,264,938		9,113,480
Other liabilities		6,763,117		6,257,387
Total liabilities		289,862,884		288,471,626

Shareholders' equity:
Common stock - no par value, stated value $.001 per share. Authorized 7,000,000 shares - 3,276,560 and 3,295,870 shares outstanding		3,277		3,296
Additional paid-in capital		35,965,153		36,567,865
Retained earnings		82,949,194		69,708,901
Accumulated other comprehensive income		9,597,996		62,495
Total UTG shareholders' equity		128,515,620		106,342,557
Noncontrolling interests		492,799		734,153
Total shareholders' equity		129,008,419		107,076,710
Total liabilities and shareholders' equity	$	418,871,303	$	395,548,336

* Balance sheet audited at December 31, 2018.

See accompanying notes.

UTG, Inc.

Condensed Consolidated Statements of Operations (Unaudited)

	Three Months Ended						Nine Months Ended
	September 30,			September 30,			September 30,			September 30,
	2019			2018			2019			2018
Revenue:
Premiums and policy fees	$	2,385,113		$	2,469,322		$	7,319,807		$	7,659,198
Ceded reinsurance premiums and policy fees		(678,941	)		(652,418	)		(2,009,252	)		(2,164,581	)
Net investment income		2,818,669			2,309,470			8,632,402			8,996,566
Other income		95,141			128,059			254,898			308,616
Revenue before net investment gains (losses)		4,619,982			4,254,433			14,197,855			14,799,799
Net investment gains (losses):
Other-than-temporary impairments		-			(300,000	)		-			(300,000	)
Other realized investment gains, net		3,727,538			12,074,120			10,143,014			12,723,566
Change in fair value of equity securities		(4,046,457	)		6,689,533			10,838,322			22,050,489
Total net investment gains (losses)		(318,919	)		18,463,653			20,981,336			34,474,055
Total revenue		4,301,063			22,718,086			35,179,191			49,273,854

Benefits and other expenses:
Benefits, claims and settlement expenses:
Life		4,029,261			4,388,733			12,047,346			12,927,216
Ceded reinsurance benefits and claims		(501,184	)		(1,044,894	)		(1,583,345	)		(1,996,044	)
Annuity		265,413			252,260			770,452			783,724
Dividends to policyholders		74,864			77,489			274,516			301,779
Commissions and amortization of deferred policy acquisition costs		(39,665	)		(34,464	)		(102,784	)		(110,920	)
Amortization of cost of insurance acquired		193,977			201,516			581,930			604,549
Operating expenses		1,940,795			3,401,169			5,875,135			7,271,820
Total benefits and other expenses		5,963,461			7,241,809			17,863,250			19,782,124

Income (loss) before income taxes		(1,662,398	)		15,476,277			17,315,941			29,491,730
Income tax (benefit) expense		(578,549	)		3,506,656			3,781,340			6,563,628

Net income (loss)		(1,083,849	)		11,969,621			13,534,601			22,928,102

Net income attributable to noncontrolling interests		(32,795	)		(32,078	)		(294,308	)		(184,565	)

Net income (loss) attributable to common shareholders	$	$ (1,116,644	)	$	11,937,543		$	13,240,293		$	22,743,537

Amounts attributable to common shareholders
Basic income (loss) per share	$	$ (0.34	)	$	3.62		$	4.03		$	6.87

Diluted income (loss) per share	$	$ (0.34	)	$	3.62		$	4.03		$	6.87

Basic weighted average shares outstanding		3,279,684			3,299,615			3,289,133			3,311,912

Diluted weighted average shares outstanding		3,279,684			3,299,615			3,289,133			3,311,912

See accompanying notes.

UTG, Inc.

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)

	Three Months Ended						Nine Months Ended
	September 30,			September 30,			September 30,			September 30,
	2019			2018			2019			2018
Net income (loss)	$	(1,083,849	)	$	11,969,621		$	13,534,601		$	22,928,102

Other comprehensive income (loss):

Unrealized holding gains (losses) arising during period, pre-tax		3,184,769			1,244,302			12,044,690			(4,982,237	)
Tax (expense) benefit on unrealized holding gains (losses) arising during the period		(668,802	)		(261,303	)		(2,529,385	)		1,046,270
Unrealized holding gains (losses) arising during period, net of tax		2,515,967			982,999			9,515,305			(3,935,967	)

Less reclassification adjustment for gains (losses) included in net income		30,793			(11,018,710	)		25,564			(11,133,914	)
Tax (expense) benefit for gains included in net income		(6,466	)		2,313,929			(5,368	)		2,338,122
Reclassification adjustment for gains (losses) included in net income, net of tax		24,327			(8,704,781	)		20,196			(8,795,792	)
Subtotal: Other comprehensive income (loss), net of tax		2,540,294			(7,721,782	)		9,535,501			(12,731,759	)

Comprehensive income (loss)		1,456,445			4,247,839			23,070,102			10,196,343

Less comprehensive income attributable to noncontrolling interests		(32,795	)		(32,078	)		(294,308	)		(184,565	)

Comprehensive income (loss) attributable to UTG, Inc.	$	1,423,650		$	4,215,761		$	22,775,794		$	10,011,778

See accompanying notes.

UTG, Inc.

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

Three Months Ended September 30, 2019	Common Stock			Additional Paid-In Capital			Retained Earnings			Accumulated Other Comprehensive Income		Noncontrolling Interest			Total Shareholders' Equity

Balance at June 30, 2019	$	3,286		$	36,253,067		$	84,065,838		$	7,057,702	$	749,916		$	128,129,809
Common stock issued during year		-			-			-			-		-			-
Treasury shares acquired		(9	)		(287,914	)		-			-		-			(287,923	)
Net income attributable to common shareholders		-			-			(1,116,644	)		-		-			(1,116,644	)
Unrealized holding income on securities net of noncontrolling interest and reclassification adjustment and taxes		-			-			-			2,540,294		-			2,540,294
Contributions		-			-			-			-		-			-
Distributions		-			-			-			-		(289,912	)		(289,912	)
Gain attributable to noncontrolling interest		-			-			-			-		32,795			32,795
Balance at September 30, 2019	$	3,277		$	35,965,153		$	82,949,194		$	9,597,996	$	492,799		$	129,008,419

Nine Months Ended September 30, 2019	Common Stock			Additional Paid-In Capital			Retained Earnings		Accumulated Other Comprehensive Income		Noncontrolling Interest			Total Shareholders' Equity

Balance at December 31, 2018	$	3,296		$	36,567,865		$	69,708,901	$	62,495	$	734,153		$	107,076,710
Common stock issued during year		7			246,527			-		-		-			246,534
Treasury shares acquired		(26	)		(849,239	)		-		-		-			(849,265	)
Net income attributable to common shareholders		-			-			13,240,293		-		-			13,240,293
Unrealized holding income on securities net of noncontrolling interest and reclassification adjustment and taxes		-			-			-		9,535,501		-			9,535,501
Contributions		-			-			-		-		-			-
Distributions		-			-			-		-		(535,662	)		(535,662	)
Gain attributable to noncontrolling interest		-			-			-		-		294,308			294,308
Balance at September 30, 2019	$	3,277		$	35,965,153		$	82,949,194	$	9,597,996	$	492,799		$	129,008,419

See accompanying notes.

UTG, Inc.

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

Three Months Ended September 30, 2018	Common Stock			Additional Paid-In Capital			Retained Earnings		Accumulated Other Comprehensive Income			Noncontrolling Interest		Total Shareholders' Equity

Balance at June 30, 2018	$	3,305		$	36,829,530		$	68,123,778	$	9,665,033		$	804,122	$	115,425,768
Common stock issued during year		-			-			-		-			-		-
Treasury shares acquired		(9	)		(264,374	)		-		-			-		(264,383	)
Net income attributable to common shareholders		-			-			11,937,543		-			-		11,937,543
Unrealized holding income on securities net of noncontrolling interest and reclassification adjustment and taxes		-			-			-		(7,721,782	)		-		(7,721,782	)
Contributions		-			-			-		-			-		-
Distributions		-			-			-		-			-		-
Gain attributable to noncontrolling interest		-			-			-		-			32,078		32,078
Balance at September 30, 2018	$	3,296		$	36,565,156		$	80,061,321	$	1,943,251		$	836,200	$	119,409,224

Nine Months Ended September 30, 2018	Common Stock			Additional Paid-In Capital			Retained Earnings		Accumulated Other Comprehensive Income			Noncontrolling Interest			Total Shareholders' Equity

Balance at December 31, 2017	$	3,333		$	37,536,164		$	39,040,456	$	32,952,338		$	899,227		$	110,431,518
Adoption of Accounting Standards Update No 2016-01		-			-			18,277,328		(18,277,328	)		-			-
January 1, 2018		3,333			37,536,164			57,317,784		14,675,010			899,227			110,431,518
Common stock issued during year		10			246,747			-		-			-			246,757
Treasury shares acquired		(47	)		(1,217,755	)		-		-			-			(1,217,802	)
Net income attributable to common shareholders		-			-			22,743,537		-			-			22,743,537
Unrealized holding income on securities net of noncontrolling interest and reclassification adjustment and taxes		-			-			-		(12,731,759	)		-			(12,731,759	)
Contributions		-			-			-		-			-			-
Distributions		-			-			-		-			(247,592	)		(247,592	)
Gain attributable to noncontrolling interest		-			-			-		-			184,565			184,565
Balance at September 30, 2018	$	3,296		$	36,565,156		$	80,061,321	$	1,943,251		$	836,200		$	119,409,224

See accompanying notes.

UTG, Inc.

Condensed Consolidated Statements of Cash Flows (Unaudited)

	Nine Months Ended
	September 30,			September 30,
	2019			2018
Cash flows from operating activities:
Net income	$	13,534,601		$	22,928,102
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments		28,936			137,899
Other-than-temporary impairments		-			300,00
Realized investment gains, net		(10,143,014	)		(12,723,566	)
Change in fair value of equity securities		(10,838,322	)		(22,050,489	)
Amortization of cost of insurance acquired		581,930			604,549
Depreciation		868,630			814,202
Stock-based compensation		246,534			246,757
Charges for mortality and administration of universal life and annuity products		(4,839,551	)		(4,948,332	)
Interest credited to account balances		3,068,614			3,177,834
Change in accrued investment income		375,806			42,511
Change in reinsurance receivables		460,659			91,579
Change in policy liabilities and accruals		(2,458,575	)		(2,613,125	)
Change in income taxes receivable (payable)		78,738			2,221,052
Change in other assets and liabilities, net		3,749,194			9,987,926
Net cash used in operating activities		(5,285,820	)		(1,783,101	)

Cash flows from investing activities:
Proceeds from investments sold and matured:
Fixed maturities available for sale		8,563,966			54,220,638
Equity securities		10,219,197			843,260
Mortgage loans		4,824,430			4,496,554
Real estate		11,620,038			12,783,088
Notes receivable		4,296,998			2,559,264
Policy loans		1,324,183			1,423,014
Short-term investments		-			2,114,000
Total proceeds from investments sold and matured		40,848,812			78,439,818
Cost of investments acquired:
Fixed maturities available for sale		(11,655,148	)		(42,955,401	)
Equity securities		(1,323,310	)		(9,538,853	)
Trading securities		(132,518	)		-
Mortgage loans		(4,216,644	)		(16,453	)
Real estate		(1,729,000	)		(10,113,852	)
Notes receivable		(8,532,796	)		(4,000,000	)
Policy loans		(973,594	)		(1,244,976	)
Short-term investments		-			(7,549,076	)
Total cost of investments acquired		(28,563,010	)		(75,418,611	)
Net cash provided by investing activities		12,285,802			3,021,207

Cash flows from financing activities:
Policyholder contract deposits		3,542,562			3,548,809
Policyholder contract withdrawals		(3,578,980	)		(2,849,310	)
Purchase of treasury stock		(849,265	)		(1,217,802	)
Non controlling contributions (distributions) of consolidated subsidiary		(535,662	)		(247,592	)
Net cash used in financing activities		(1,421,345	)		(765,895	)

Net increase in cash and cash equivalents		5,578,637			472,211
Cash and cash equivalents at beginning of period		20,150,162			25,434,199
Cash and cash equivalents at end of period	$	25,728,799		$	25,906,410

See accompanying notes.

UTG, Inc.

Notes to Condensed Consolidated Financial Statements

Note 1 – Basis of Presentation

The accompanying Condensed Consolidated Balance Sheet as of December 31, 2018, which has been derived from audited consolidated financial statements, and the unaudited interim Condensed Consolidated Financial Statements include the accounts of UTG, Inc. (the “Parent”) and its subsidiaries (collectively with the Parent, the “Company”). All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for audited annual financial statements. The information furnished includes all adjustments and accruals of a normal recurring nature, which in the opinion of Management, are necessary for a fair presentation of the results for the interim periods. The unaudited Condensed Consolidated Financial Statements included herein and these related notes should be read in conjunction with the Company’s consolidated financial statements, and the notes thereto, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. The Company’s results of operations for the three and nine months ended September 30, 2019 are not necessarily indicative of the results that may be expected for the year ending December 31, 2019 or for any other future period.

This document at times will refer to the Registrant’s largest shareholder, Mr. Jesse T. Correll and certain companies controlled by Mr. Correll. Mr. Correll holds a majority ownership of First Southern Funding, LLC (“FSF”), a Kentucky corporation, and First Southern Bancorp, Inc. (“FSBI”), a financial services holding company. FSBI operates through its 100% owned subsidiary bank, First Southern National Bank (“FSNB”). Banking activities are conducted through multiple locations within south-central and western Kentucky. Mr. Correll is Chief Executive Officer and Chairman of the Board of Directors of UTG and is currently UTG’s largest shareholder through his ownership control of FSF, FSBI and affiliates. At September 30, 2019, Mr. Correll owns or controls directly and indirectly approximately 65.66% of UTG’s outstanding stock.

UTG’s life insurance subsidiary, Universal Guaranty Life Insurance Company (“UG”), has several wholly-owned and majority-owned subsidiaries. The subsidiaries were formed to hold certain real estate investments. The real estate investments were placed into the limited liability companies and partnerships to provide additional protection to the policyholders and to UG.

Certain amounts in prior periods have been reclassified to conform with the current period presentation.

Note 2 – Recently Issued Accounting Standards

During the nine months ended September 30, 2019, there were no additions to or changes in the critical accounting policies disclosed in the 2018 Form 10-K.

Note 3 – Investments

Available for Sale Securities – Fixed Maturity Securities

The Company’s insurance subsidiary is regulated by insurance statutes and regulations as to the type of investments they are permitted to make, and the amount of funds that may be used for any one type of investment.

Investments in available for sale securities are summarized as follows:

September 30, 2019	Original or Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Investments available for sale:
Fixed maturities
U.S. Government and govt. agencies and authorities	$	35,283,800	$	483,968	$	(333	)	$	35,767,435
U.S. special revenue and assessments		14,376,048		1,002,030		(99	)		15,377,979
All other corporate bonds		113,632,040		11,224,997		-			124,857,037
	$	163,291,888	$	12,710,995	$	(432	)	$	176,002,451

December 31, 2018	Original or Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Investments available for sale:
Fixed maturities
U.S. Government and govt. agencies and authorities	$	25,649,410	$	149,006	$	(138,222	)	$	25,660,194
U.S. special revenue and assessments		16,350,486		334,300		(4,406	)		16,680,380
All other corporate bonds		118,895,973		2,569,287		(2,845,050	)		118,620,210
	$	160,895,869	$	3,052,593	$	(2,987,678	)	$	160,960,784

The amortized cost and estimated market value of debt securities at September 30, 2019, by contractual maturity, is shown below. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.

Fixed Maturities Available for Sale September 30, 2019	Amortized Cost		Fair Value
Due in one year or less	$	2,500,083	$	2,499,750
Due after one year through five years		62,005,611		64,052,446
Due after five years through ten years		50,915,439		56,800,689
Due after ten years		47,870,755		52,649,566
Total	$	163,291,888	$	176,002,451

The fair value of investments with sustained gross unrealized losses at September 30, 2019 and December 31, 2018 are as follows:

September 30, 2019	Less than 12 months					12 months or longer					Total
	Fair value		Unrealized losses			Fair value		Unrealized losses			Fair value		Unrealized losses
U.S. Government and govt. agencies and authorities	$	-		-			2,499,750		(333	)		2,499,750	$	(333	)
U.S. special revenue and assessments		2,027,140		(99)			-		-			2,027,140		(99)
Total fixed maturities	$	2,027,140		(99	)		2,499,750		(333	)		4,526,890	$	(432	)

December 31, 2018	Less than 12 months					12 months or longer					Total
	Fair value		Unrealized losses			Fair value		Unrealized losses			Fair value		Unrealized losses
U.S. Government and govt. agencies and authorities	$	6,429,700		(49,904	)		1,592,679		(88,318	)		8,022,379	$	(138,222	)
U.S. special revenue and assessments		4,023,920		(4,406	)		-		-			4,023,920		(4,406	)
All other corporate bonds		49,270,729		(2,033,507	)		15,337,739		(811,543	)		64,608,468		(2,845,050	)
Total fixed maturities	$	59,724,349		(2,087,817	)		16,930,418		(899,861	)		76,654,767	$	(2,987,678	)

Additional information regarding investments in an unrealized loss position is as follows:

	Less than 12 months	12 months or longer	Total
As of September 30, 2019
Fixed maturities	1	1	2
As of December 31, 2018
Fixed maturities	30	10	40

Substantially all of the unrealized losses on fixed maturities at September 30, 2019 and December 31, 2018 are attributable to changes in market interest rates and general disruptions in the credit market subsequent to purchase. The Company does not currently intend to sell nor does it expect to be required to sell any of the securities in an unrealized loss position. Based upon the Company’s expected continuation of receipt of contractually required principal and interest payments and its intent and ability to retain the securities until price recovery, as well as the Company’s evaluation of other relevant factors, the Company deems these securities to be temporarily impaired as of September 30, 2019 and December 31, 2018.

Net Investment Gains (Losses)

The following table presents net investment gains (losses) and the change in net unrealized gains (losses) on available-for-sale investments.

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2019			2018			2019			2018
Realized gains:
Sales of fixed maturities	$	-		$	11,018,711		$	116,690		$	11,392,373
Sales of equity securities		3,738,333			-			6,504,246			-
Sales of real estate		20,000			1,055,409			3,796,850			1,589,651
Other		-			-			-			-
Total realized gains		3,758,333			12,074,120			10,417,786			12,982,024
Realized losses:
Sales of fixed maturities		(30,795	)		-			(142,254	)		(258,458	)
Sales of equity securities		-			-			-			-
Sales of real estate		-			-			-			-
Other-than-temporary impairments		-			(300,000	)		-			(300,000	)
Other		-			-			(132,518	)		-
Total realized losses		(30,795	)		(300,000	)		(274,772	)		(558,458	)
Net realized investment gains (losses)		3,727,538			11,774,120			10,143,014			12,423,566
Change in fair value of equity securities:
Change in fair value of equity securities held at the end of the period		(4,046,457	)		6,689,533			10,838,322			22,050,489
Change in fair value of equity securities		(4,046,457	)		6,689,533			10,838,322			22,050,489
Net investment gains (losses)	$	(318,919	)	$	18,463,653		$	20,981,336		$	34,474,055
Change in net unrealized gains (losses) on available-for-sale investments included in other comprehensive income:
Fixed maturities	$	3,184,769		$	1,244,302		$	12,044,690		$	(4,982,237	)
Equity securities		-			-			-			-
Net increase (decrease)	$	3,184,769		$	1,244,302		$	12,044,690		$	(4,982,237	)

Other-Than-Temporary Impairments

The Company regularly reviews its investment securities for factors that may indicate that a decline in fair value of an investment is other than temporary. The factors considered by Management in its regular review to identify and recognize other-than-temporary impairment losses on fixed maturities include, but are not limited to: the length of time and extent to which the fair value has been less than cost; the Company’s intent to sell, or be required to sell, the debt security before the anticipated recovery of its remaining amortized cost basis; the financial condition and near-term prospects of the issuer; adverse changes in ratings announced by one or more rating agencies; subordinated credit support, whether the issuer of a debt security has remained current on principal and interest payments; current expected cash flows; whether the decline in fair value appears to be issuer specific or, alternatively, a reflection of general market or industry conditions, including the effect of changes in market interest rates. If the Company intends to sell a debt security, or it is more likely than not that it would be required to sell a debt security before the recovery of its amortized cost basis, the entire difference between the security’s amortized cost basis and its fair value at the balance sheet date would be recognized by a charge to other-than-temporary losses in the Condensed Consolidated Statements of Operations.

Management regularly reviews its real estate portfolio in comparison to appraisal valuations and current market conditions for indications of other-than-temporary impairments. If a decline in value is judged by Management to be other-than-temporary, a loss is recognized by a charge to other-than-temporary impairment losses in the Consolidated Statements of Operations.

The Company did not recognize any other-than-temporary impairments during the nine months ended September 30, 2019. During the third quarter of 2018, the Company recognized an other-than-temporary impairment on real estate. The other-than-temporary impairment was taken as a result of Management's assessment and determination of value of the real estate. The real estate was written down to better reflect its current expected value.

Cost Method Investments

The Company held equity investments with an aggregate cost of $11,289,805 and $12,118,617 at September 30, 2019 and December 31, 2018, respectively. These equity investments were not reported at fair value because it is not practicable to estimate their fair values due to insufficient information being available. Management did not identify any events or changes in circumstances that might have a significant adverse effect on the reported value of those investments. Based on Management's evaluation of the expected cash flow of the investments, and the Company's ability and intent to hold the investments for a reasonable period of time, the Company does not deem an other-than-temporary impairment necessary at September 30, 2019.

Mortgage Loans

The Company, from time to time, acquires mortgage loans through participation agreements with FSNB. FSNB has been able to provide the Company with additional expertise and experience in underwriting commercial and residential mortgage loans, which provide more attractive yields than the traditional bond market. The Company is able to receive participations from FSNB for three primary reasons: 1) FSNB has already reached its maximum lending limit to a single borrower, but the borrower is still considered a suitable risk; 2) the interest rate on a particular loan may be fixed for a long period that is more suitable for UG given its asset-liability structure; and 3) FSNB’s loan growth might at times outpace its deposit growth, resulting in FSNB participating such excess loan growth rather than turning customers away. For originated loans, the Company’s Management is responsible for the final approval of such loans after evaluation. Before a new loan is issued, the applicant is subject to certain criteria set forth by Company Management to ensure quality control. These criteria include, but are not limited to, a credit report, personal financial information such as outstanding debt, sources of income, and personal equity. Once the loan is approved, the Company directly funds the loan to the borrower. The Company bears all risk of loss associated with the terms of the mortgage with the borrower.

During the nine months ended September 30, 2019 and 2018, the Company acquired $4,216,644 and $16,453 in mortgage loans, respectively. FSNB services the majority of the Company’s mortgage loan portfolio. The Company pays FSNB a .25% servicing fee on these loans and a one-time fee at loan origination of .50% of the original loan cost to cover costs incurred by FSNB relating to the processing and establishment of the loan.

During 2019 and 2018, the maximum and minimum lending rates for mortgage loans were:

	2019		2018
	Maximum rate	Minimum rate	Maximum rate	Minimum rate
Farm Loans	5.00%	5.00%	5.00%	5.00%
Commercial Loans	7.50%	4.82%	7.50%	4.00%
Residential Loans	5.50%	5.50%	8.00%	8.00%

Most mortgage loans are first position loans. Loans issued are generally limited to no more than 80% of the appraised value of the property.

The Company has in place a monitoring system to provide Management with information regarding potential troubled loans. Letters are sent to each mortgagee when the loan becomes 30 days or more delinquent. Management is provided with a monthly listing of loans that are 60 days or more past due along with a brief description of what steps are being taken to resolve the delinquency. All loans 90 days or more past due are placed on a non-performing status and classified as delinquent loans. Quarterly, coinciding with external financial reporting, the Company reviews each delinquent loan and determines how each delinquent loan should be classified. Management believes the current internal controls surrounding the mortgage loan selection process provide a quality portfolio with minimal risk of foreclosure and/or negative financial impact.

Changes in the current economy could have a negative impact on the loans, including the financial stability of the borrowers, the borrowers’ ability to pay or to refinance, the value of the property held as collateral and the ability to find purchasers at favorable prices. Interest accruals are analyzed based on the likelihood of repayment. In no event will interest continue to accrue when accrued interest along with the outstanding principal exceeds the net realizable value of the property. The Company does not utilize a specified number of days delinquent to cause an automatic non-accrual status.

A mortgage loan reserve is established and adjusted based on Management's quarterly analysis of the portfolio and any deterioration in value of the underlying property which would reduce the net realizable value of the property below its current carrying value. The mortgage loan reserve was $0 at September 30, 2019 and December 31, 2018.

The following table summarizes the mortgage loan holdings of the Company for the periods ended:

	September 30, 2019		December 31, 2018
In good standing	$	6,695,892	$	7,169,272
Overdue interest over 90 days		1,830,706		1,899,839
Total mortgage loans	$	8,526,598	$	9,069,111

Investment Real Estate

Real estate acquired through foreclosure, consisting of properties obtained through foreclosure proceedings or acceptance of a deed in lieu of foreclosure, is reported on an individual asset basis at the lower of cost or fair value, less disposal costs. Fair value is determined on the basis of current appraisals, comparable sales, and other estimates of value obtained principally from independent sources. When properties are acquired through foreclosure, any excess of the loan balance at the time of foreclosure over the fair value of the real estate held as collateral is recognized and charged to the Consolidated Statements of Operations. Based upon Management’s evaluation of the real estate acquired through foreclosure, additional expense is recorded when necessary in an amount sufficient to reflect any declines in estimated fair value. Gains and losses recognized on the disposition of the properties are recorded as realized gains and losses in the Condensed Consolidated Statements of Operations.

Notes Receivable

Notes receivable represent collateral loans and promissory notes issued by the Company and are reported at their unpaid principal balances, adjusted for valuation allowances. Valuation allowances are established for impaired loans when it is probable that contractual principal and interest will not be collected. The valuation allowance as of September 30, 2019 and December 31, 2018 was $0. Interest accruals are analyzed based on the likelihood of repayment. The Company does not utilize a specified number of days delinquent to cause an automatic non-accrual status. During the nine months ended September 30, 2019 and 2018 the Company acquired $8,532,796 and $4,000,000, respectively.

Before a new note is issued, the applicant is subject to certain criteria set forth by Company Management to ensure quality control. Once the note is approved, the Company directly funds the note to the borrower. Several of the notes have participation agreements in place, whereas the Company has reduced its investment in the note receivable by participating a portion of the note to a third party.

Similar to the mortgage loans, FSNB services several of the notes receivable. The Company, and the participants in the notes, share in the risk of loss associated with the terms of the note with the borrower, based upon their ownership percentage in the note. The Company has in place a monitoring system to provide Management with information regarding potential troubled loans.

Note 4 – Fair Value Measurements

The Company measures its assets and liabilities recorded at fair value in the Condensed Consolidated Balance Sheets based on the framework set forth in the GAAP fair value accounting guidance. The framework establishes a fair value hierarchy of three levels based upon the transparency of information used in measuring the fair value of assets or liabilities as of the measurement date. The fair value hierarchy prioritizes the inputs in the valuation techniques used to measure fair value into three categories.

Level 1 – Valuation is based upon quoted prices for identical assets or liabilities in active markets that the Company is able to access. Level 1 fair value is not subject to valuation adjustments.

Level 2 – Valuation is based upon quoted prices for similar assets and liabilities in active markets or quoted prices for identical or similar instruments in markets that are not active. In addition, the Company may use various valuation techniques or pricing models that use observable inputs to measure fair value.

Level 3 – Valuation is based upon unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Unobservable inputs reflect the Company’s own assumptions about the inputs that market participants would use in pricing the asset or liability.

The Company determines the existence of an active market for an asset or liability based on its judgment as to whether transactions for the asset or liability occur in such market with sufficient frequency and volume to provide reliable pricing information. If the Company concludes that there has been a significant decrease in the volume and level of activity for an investment in relation to normal market activity for such investment, adjustments to transactions and quoted prices are made to estimate fair value.

The inputs used in the valuation techniques employed by the Company are provided by nationally recognized pricing services, external investment managers and internal resources. To assess these inputs, the Company’s review process includes, but is not limited to, quantitative analysis including benchmarking, initial and ongoing evaluations of methodologies used by external parties to calculate fair value, and ongoing evaluations of fair value estimates based on the Company’s knowledge and monitoring of market conditions.

The Company periodically reviews the pricing service provider’s policies and procedures for valuing securities. The assumptions underlying the valuations from external service providers, including unobservable inputs, are generally not readily available as this information is often deemed proprietary. Accordingly, the Company is unable to obtain comprehensive information regarding these assumptions and methodologies.

The Company’s investments in fixed maturity securities available for sale, equity securities and trading securities assets and liabilities are carried at fair value. The following are the Company’s methodologies and valuation techniques for assets and liabilities measured at fair value.

Fixed maturities available for sale mainly consist of U.S. treasury securities and corporate debt securities. The Company employs a market approach to the valuation of securities where there are sufficient market transactions involving identical or comparable assets. If sufficient market data is not available for identical or comparable assets, the Company uses an income approach to valuation. The majority of the financial instruments included in fixed maturity securities available for sale are evaluated utilizing observable inputs; accordingly, they are categorized in either Level 1 or Level 2 of the fair value hierarchy. However, in instances where significant inputs utilized in valuation of the securities are unobservable, the securities are categorized in Level 3 of the fair value hierarchy.

Corporate securities primarily include fixed rate corporate bonds. Inputs utilized in connection with the Company’s valuation techniques relating to this class of securities include recently executed transactions, market price quotations, benchmark yields and issuer spreads. Corporate securities are categorized in Level 2 of the fair value hierarchy.

U.S. treasury securities are based on quoted prices in active markets and are generally categorized in Level 1 of the fair value hierarchy.

Equity securities consist of common and preferred stocks mainly in private equity investments, financial institutions and publicly traded corporations. Equity securities for which there is sufficient market data are categorized as Level 1 or 2 in the fair value hierarchy. For the equity securities in which quoted market prices are not available, the Company uses industry standard pricing methodologies, including discounted cash flow models that may incorporate various inputs such as payment expectations, risk of the investment, market data, and health of the underlying company. The inputs are based upon Management's assumptions and available market information. When evidence is believed to support a change to the carrying value from the transaction price, adjustments are made to reflect the expected cash flows, material events and market data. These investments are included in Level 3 of the fair value hierarchy.

The following table presents the Company’s assets and liabilities measured at fair value in the Condensed Consolidated Balance Sheet on a recurring basis as of September 30, 2019.

	Level 1		Level 2		Level 3		Total
Assets
Fixed Maturities, available for sale	$	35,767,435	$	139,812,089	$	422,927	$	176,002,451
Equity Securities		29,232,731		14,328,980		33,378,263		76,939,974
Total	$	65,000,166	$	154,141,069	$	33,801,190	$	252,942,425

The following table presents the Company’s assets and liabilities measured at fair value in the Condensed Consolidated Balance Sheet on a recurring basis as of December 31, 2018.

	Level 1		Level 2		Level 3		Total
Assets
Fixed Maturities, available for sale	$	25,660,194	$	134,865,746	$	434,844	$	160,960,784
Equity Securities		27,634,283		10,557,031		29,473,168		67,664,482
Total	$	53,294,477	$	145,422,777	$	29,908,012	$	228,625,266

The following table provides reconciliations for Level 3 assets measured at fair value on a recurring basis. Transfers into and out of Level 3 are recognized as of the end of the quarter in which they occur.

	Fixed Maturities, Available for Sale			Equity Securities			Total
Balance at December 31, 2018	$	434,844		$	29,473,168		$	29,908,012
Total unrealized gain or (losses):
Included in net income (loss)		-			5,937,050			5,937,050
Included in other comprehensive income		-			-			-
Purchases		-			275,720			275,720
Sales		(11,917	)		(2,307,675	)		(2,319,592	)
Balance at September 30, 2019	$	422,927		$	33,378,263		$	33,801,190

		September 30, 2019				December 31, 2018
Change in fair value of equity securities included in net income (loss) relating to assets held		$	5,937,050			$	4,633,751

The Level 3 securities include collateralized debt obligations of trust preferred securities issued by banks and insurance companies and certain equity securities with unobservable inputs. The Company computed fair value of Level 3 equity investments based on a review of current financial information, earnings trends and similar companies in the same industries.

There were no transfers in or out of Level 3 as of September 30, 2019. Transfers occur when there is a change in the availability of observable market information.

Certain assets are not carried at fair value on a recurring basis, including investments such as mortgage loans and policy loans. Accordingly, such investments are only included in the fair value hierarchy disclosure when the investment is subject to re-measurement at fair value after initial recognition and the resulting re-measurement is reflected in the Consolidated Financial Statements.

The carrying values and estimated fair values of certain of the Company’s financial instruments not recorded at fair value in the Consolidated Balance Sheets are shown below. Because the fair value for all Consolidated Balance Sheet items are not required to be disclosed, the aggregate fair value amounts presented below are not reflective of the underlying value of the Company.

	September 30, 2019				December 31, 2018
Assets	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Equity securities	$	11,289,805	$	11,289,805	$	12,118,617	$	12,118,617
Mortgage loans on real estate		8,526,598		8,526,598		9,069,111		9,069,111
Investment real estate		45,796,423		45,796,423		52,518,577		52,518,577
Notes receivable		27,953,110		27,953,110		23,717,312		23,717,312
Policy loans		8,853,633		8,853,633		9,204,222		9,204,222
Cash and cash equivalents		25,728,799		25,728,799		20,150,162		20,150,162

The above estimated fair value amounts have been determined based upon the following valuation methodologies. Considerable judgment was required to interpret market data in order to develop these estimates. Accordingly, the estimates are not necessarily indicative of the amounts which could be realized in a current market exchange. The use of different market assumptions or estimation methodologies may have a material effect on the fair value amounts.

The fair values of mortgage loans on real estate are estimated using discounted cash flow analyses and interest rates being offered for similar loans to borrowers with similar credit ratings. The inputs used to measure the fair value of our mortgage loans on real estate are classified as Level 3 within the fair value hierarchy.

A portion of the mortgage loans balance consists of discounted mortgage loans. The Company has historically purchased non-performing discounted mortgage loans at a deep discount through an auction process led by the Federal Government. In general, the discounted loans are non-performing and there is a significant amount of uncertainty surrounding the timing and amount of cash flows to be received by the Company. Accordingly, the Company records its investment in the discounted loans at its original purchase price, which Management believes approximates fair value. The inputs used to measure the fair value of our discounted mortgage loans are classified as Level 3 within the fair value hierarchy

Investment real estate is recorded at the lower of the net investment in the real estate or the fair value of the real estate less costs to sell. The determination of fair value assessments are performed on a periodic, non-recurring basis by external appraisal and assessment of property values by Management. The inputs used to measure the fair value of our investment real estate are classified as Level 3 within the fair value hierarchy.

Notes receivable are carried at their unpaid principal balances, which approximates fair value. The inputs used to measure the fair value of the loans are classified as Level 3 within the fair value hierarchy.

Policy loans are carried at the aggregate unpaid principal balances in the Condensed Consolidated Balance Sheets which approximate fair value, and earn interest at rates ranging from 4% to 8%. Individual policy liabilities in all cases equal or exceed outstanding policy loan balances. The inputs used to measure the fair value of our policy loans are classified as Level 3 within the fair value hierarchy.

The carrying amount of cash and cash equivalents in the Condensed Consolidated Balance Sheets approximates fair value given the highly liquid nature of the instruments. The inputs used to measure the fair value of our cash and cash equivalents are classified as Level 1 within the fair value hierarchy.

The carrying amount of short term investments in the Condensed Consolidated Balance Sheets approximates fair value. The inputs used to measure the fair value of our short term investments are classified as Level 3 within the fair value hierarchy.

Note 5 – Credit Arrangements

Instrument	Issue Date	Maturity Date	Revolving Credit Limit		December 31, 2018		Borrowings		Repayments		September 30, 2019
Lines of Credit:
UTG	11/20/2013	11/20/2019	$	8,000,000		-		-		-		-
UG	6/2/2015	5/8/2020		10,000,000		-		-		-		-

The UTG line of credit carries interest at a fixed rate of 5.125% and is payable monthly. As collateral, UTG has pledged 100% of the common voting stock of its wholly owned subsidiary, Universal Guaranty Life Insurance Company.

During May of 2019, the Federal Home Loan Bank approved UG’s Cash Management Advance Application (“CMA”). The CMA gives the Company the option of selecting a variable rate of interest for up to 90 days or a fixed rate for a maximum of 30 days. The variable rate CMA is prepayable at any time without a fee, while the fixed CMA is not prepayable prior to maturity. The Company is currently in the process of renewing the CMA.

Note 6 – Shareholders’ Equity

Stock Repurchase Program – The Board of Directors of UTG has authorized the repurchase in the open market or in privately negotiated transactions of UTG's common stock. At a meeting of the Board of Directors in June of 2019, the Board of Directors of UTG authorized the repurchase of up to an additional $2.5 million of UTG's common stock, for a total repurchase of up to $18.5 million of UTG's common stock in the open market or in privately negotiated transactions. Company Management has broad authority to operate the program, including the discretion of whether to purchase shares and the ability to suspend or terminate the program. Open market purchases are made based on the last available market price but may be limited. During the nine months ended September 30, 2019, the Company repurchased 27,498 shares through the stock repurchase program for $849,265. Through September 30, 2019, UTG has spent $14,712,994 in the acquisition of 1,167,604 shares under this program.

During 2019, the Company issued 8,188 shares of stock to management and employees as compensation at a cost of $246,534. These awards are determined at the discretion of the Board of Directors.

Earnings Per Share Calculations

Earnings per share are based on the weighted average number of common shares outstanding during each period. For the nine months ended September 30, 2019 and 2018, diluted earnings per share were the same as basic earnings per share since the Company had no dilutive instruments outstanding.

Note 7 – Commitments and Contingencies

The insurance industry has experienced a number of civil jury verdicts which have been returned against life and health insurers in the jurisdictions in which the Company does business involving the insurers' sales practices, alleged agent misconduct, failure to properly supervise agents, and other matters. Some of the lawsuits have resulted in the award of substantial judgments against the insurer, including material amounts of punitive damages. In some states, juries have substantial discretion in awarding punitive damages in these circumstances. In the normal course of business, the Company is involved from time to time in various legal actions and other state and federal proceedings. Management is of the opinion that the ultimate disposition of the matters will not have a materially adverse effect on the Company’s results of operations or financial position.

Under the insurance guaranty fund laws in most states, insurance companies doing business in a participating state can be assessed up to prescribed limits for policyholder losses incurred by insolvent or failed insurance companies. Although the Company cannot predict the amount of any future assessments, most insurance guaranty fund laws currently provide that an assessment may be excused or deferred if it would threaten an insurer's financial strength. Mandatory assessments may be partially recovered through a reduction in future premium tax in some states. The Company does not believe such assessments will be materially different from amounts already provided for in the condensed consolidated financial statements, though the Company has no control over such assessments.

The following table represents the total funding commitments and the unfunded commitment as of September 30, 2019 related to certain investments:

	Total Funding Commitment		Unfunded Commitment
RLF III, LLC	$	4,000,000	$	398,120
Sovereign’s Capital, LP Fund I		500,000		24,493
Sovereign's Capital, LP Fund II		1,000,000		158,596
Sovereign's Capital, LP Fund III		1,000,000		800,000
Barton Springs Music, LLC		1,750,000		1,064,750

During 2006, the Company committed to invest in RLF III, LLC (“RLF”), which makes land-based investments in undervalued assets. RLF makes capital calls as funds are needed for continued land purchases.

During 2012, the Company committed to invest in Sovereign’s Capital, LP Fund I (“Sovereign’s”), which invests in companies in emerging markets. Sovereign’s makes capital calls to investors as funds are needed.

During 2015, the Company committed to invest in Sovereign’s Capital, LP Fund II (“Sovereign’s II”), which invests in companies in emerging markets. Sovereign’s II makes capital calls to investors as funds are needed.

During 2018, the Company committed to invest in Sovereign’s Capital, LP Fund III (“Sovereign’s III”), which invests in companies in emerging markets. Sovereign’s III makes capital calls to investors as funds are needed.

During 2018, the Company committed to invest in Barton Springs Music, LLC (“Barton”), which invests in music royalties. Barton makes capital calls to its investors as funds are needed to acquire the royalty rights.

Note 8 – Other Cash Flow Disclosures

On a cash basis, the Company paid the following expenses:

	Three Months Ended
	September 30,
	2019			2018
Interest		$	-		$	-
Federal income tax			-			-

	Nine Months Ended
	September 30,
	2019			2018
Interest		$	-		$	-
Federal income tax			1,106,000			67,000

Note 9 – Concentrations of Credit Risk

The Company maintains cash balances in financial institutions that at times may exceed federally insured limits. The Company maintains its primary operating cash accounts with First Southern National Bank, an affiliate of the largest shareholder of UTG, Mr. Jesse Correll, the Company’s CEO and Chairman. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents.

Because UTG serves primarily individuals located in four states, the ability of our customers to pay their insurance premiums is impacted by the economic conditions in these areas. As of September 30, 2019 and 2018 , approximately 56% and 55%, respectively, of the Company’s total direct premium was collected from Illinois, Ohio, Texas and West Virginia. Thus, results of operations are heavily dependent upon the strength of these economies.

The Company reinsures that portion of insurance risk which is in excess of its retention limits. Retention limits range up to $125,000 per life. Life insurance ceded represented 20% of total life insurance in force at September 30, 2019 and December 31, 2018. Insurance ceded represented 37% and 33% of premium income for the three months ended September 30, 2019 and 2018, respectively. The Company would be liable for the reinsured risks ceded to other companies to the extent that such reinsuring companies are unable to meet their obligations.

The Company owns a variety of investments associated with the oil and gas industry. These investments represent approximately 24% and 25% of the Company's total invested assets as of September 30, 2019 and December 31, 2018, respectively.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following is Management’s discussion and analysis of the financial condition and results of operations of UTG, Inc. and its subsidiaries (collectively with the Parent, the “Company”). The following discussion of the financial condition and results of operations of the Company should be read in conjunction with, and is qualified in its entirety by reference to, the Consolidated Financial Statements of the Company and the related Notes thereto appearing in the Company’s annual report on Form 10-K for the year ended December 31, 2018, as filed with the Securities and Exchange Commission, and our unaudited Condensed Consolidated Financial Statements and related Notes thereto appearing elsewhere in this quarterly report.

Cautionary Statement Regarding Forward-Looking Statements

This report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created by those laws. We have based our forward-looking statements on our current expectations and projections about future events. Our forward-looking statements include information about possible or assumed future results of operations. All statements, other than statements of historical facts, included or incorporated by reference in this report that address activities, events or developments that we expect or anticipate may occur in the future, including such things as the growth of our business and operations, our business strategy, competitive strengths, goals, plans, future capital expenditures and references to future successes may be considered forward-looking statements. Also, when we use words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “probably,” or similar expressions, we are making forward-looking statements.

Numerous risks and uncertainties may impact the matters addressed by our forward-looking statements, any of which could negatively and materially affect our future financial results and performance.

Although we believe that the assumptions underlying our forward-looking statements are reasonable, any of these assumptions, and, therefore, the forward-looking statements based on these assumptions, could themselves prove to be inaccurate. In light of the significant uncertainties inherent in the forward-looking statements that are included in this report, our inclusion of this information is not a representation by us or any other person that our objectives and plans will be achieved. In light of these risks, uncertainties and assumptions, any forward-looking event discussed in this report may not occur. Our forward-looking statements speak only as of the date made, and we undertake no obligation to update or review any forward-looking statement, whether as a result of new information, future events or other developments, unless the securities laws require us to do so.

Overview

UTG, Inc., a Delaware corporation, is a life insurance holding company. The Company’s dominant business is individual life insurance, which includes the servicing of existing insurance policies in force, the acquisition of other companies in the life insurance business, the acquisition of blocks of business and the administration and processing of life insurance business for other entities.

UTG has a strong philanthropic program. The Company generally allocates a portion of its earnings to be used for its philanthropic efforts primarily targeted to Christ-centered organizations or organizations that help the weak or poor. The Company also encourages its staff to be involved on a personal level through monetary giving, volunteerism, and use of their talents to assist those less fortunate than themselves. Through these efforts, the Company hopes to make a positive difference in the local community, state, nation and world.

Critical Accounting Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts and related disclosures. Actual results could differ significantly from those estimates. The Company has identified certain estimates that involve a higher degree of judgment and are subject to a significant degree of variability. The Company’s critical accounting policies and the related estimates considered most significant by Management are disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. Management has identified the accounting policies related to cost of insurance acquired, assumptions and judgments utilized in determining if declines in fair values of investments are other-than-temporary, and valuation methods for investments that are not actively traded as those, due to the judgments, estimates and assumptions inherent in those policies, are critical to an understanding of the Company’s Condensed Consolidated Financial Statements and this Management’s Discussion and Analysis.

During the nine months ended September 30, 2019, there were no additions to or changes in the critical accounting policies disclosed in the 2018 Form 10-K.

Results of Operations

On a consolidated basis, the Company reported net income attributable to common shareholders’ of approximately $13.2 million for the nine-month period ended September 30, 2019 and a net loss attributable to common shareholders’ of approximately ($1.1) million for the three-month period ended September 30, 2019. For the nine-month period ended September 30, 2018, the Company reported net income attributable to common shareholders’ of approximately $22.7 million and net income attributable to common shareholders’ of approximately $12 million for the three-month period ended September 30, 2018.

Revenues

The Company reported total revenues of approximately $35.2 million for the nine months ended September 30, 2019, a decrease of approximately $14.1 million as compared to the same period in 2018. The Company reported total revenues of approximately $4.3 million for the three months ended September 30, 2019, a decrease of approximately $18.4 million as compared to the three month period ended September 30, 2018. The variance in the total revenues for the third quarter and year to date 2019, as compared to the prior year, are mainly attributable to the amounts reported for realized investment gains and losses and the change in the fair value of equity securities.The variance in total revenues from the prior year to the current year is mainly attributable to approximately $11.2 million of unrealized losses related to the change in the fair value of equity securities combined with $2.6 million less in net realized gains. For the quarter, the fluctuations relate to the sale of certain stocks that resulted in $3.7 million of realized gains combined with the change in the fair value of equity securities.

Premium and policy fee revenues, net of reinsurance, decreased approximately 3% when comparing the nine-month period ended September 30, 2019 to the same period in 2018. Premium and policy fee revenues, net of reinsurance, decreased by approximately 6% when comparing the third quarter of 2019 to the same quarter in 2018. The Company writes minimal new business. Premium and policy fee revenues, net of reinsurance, represented 15% and 11% of the Company’s revenues as of September 30, 2019 and 2018, respectively.

The following table summarizes our investment performance.

	Three Months Ended							Nine Months Ended
	September 30,							September 30,
	2019				2018			2019			2018
Net investment income		$	2,818,669			$	2,309,470		$	8,632,402		$	8,996,566
Net investment gains (losses)		$	(318,919	)		$	18,463,653		$	20,981,336		$	34,474,055
Change in net unrealized investment gains (losses) on available-for-sale securities, pre-tax		$	3,184,769			$	1,244,302		$	12,044,690		$	(4,982,237	)

The Company reported net investment losses of approximately $319,000 and gains of $21 million for the three and nine-months ended September 30, 2019, respectively. For the three and nine-months ended September 30, 2018, the Company reported net investment gains of $18.5 million and $34.5 million, respectively. For the third quarter of 2019, realized investment gains consisted of approximately $3.7 million from equities sold. The same period in 2018 had total realized investment gains of $12.1 million, which is largely a result of discounted bonds that were sold in the third quarter, resulting in realized gains of approximately $10 million. The Company also sold three parcels of real estate in 2018 that resulted in $1.3 million of realized gains.

Also included in net investments gains are unrealized gains related to the change in fair value of equity securities. The Company reported unrealized equity losses of $4 million and gains of $10.8 million for the three and nine months ended September 30, 2019. For the three and nine months ended September 30, 2018, the Company reported a change in fair value of equity securities of $6.7 million and $22.1 million. This line item is affected by changes in the market value of the Company’s equity holdings and when equities are sold as occurred in the second and third quarters of 2019. The Company has seen significant unrealized gains on its equity investments during 2018 and 2019. Significant portions of these gains are from two equity holdings, both in the area of oil and gas. While the Company has had very strong unrealized gains during 2018 and 2019, a pullback in the stock market, particularly in the oil and gas arena, could slow these gains or even result in future-period unrealized losses. During the third quarter of 2019, these securities produced unrealized losses of approximately $3 million; however, Management believes these equities continue to be solid investments.

The following table reflects net investment income of the Company:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2019			2018			2019			2018

Fixed maturities available for sale	$	1,445,341		$	1,887,731		$	4,371,895		$	5,650,502
Equity securities		287,462			431,176			1,256,794			1,303,489
Trading securities		-			-			-			-
Mortgage loans		83,528			267,137			369,132			673,209
Real estate		881,705			531,892			2,141,339			2,396,586
Notes receivable		485,288			599,622			1,435,947			1,133,129
Policy loans		149,979			156,520			460,995			485,630
Short term		-			236,397			-			331,898
Cash and cash equivalents		58,573			6,109			146,435			11,863
Total consolidated investment income		3,391,876			4,116,584			10,182,537			11,986,306
Investment expenses		(573,207	)		(1,807,114	)		(1,550,135	)		(2,989,740	)
Consolidated net investment income	$	2,818,669		$	2,309,470		$	8,632,402		$	8,996,566

Net investment income represented 25% and 18% of the Company’s total revenues as of September 30, 2019 and 2018, respectively. The Company reported net investment income of approximately $8.6 million for the nine months ended September 30, 2019, a decrease of approximately 4% compared to the same period in 2018. For the three month period ended September 30, 2019, net investment income increased approximately 22%, compared to the same quarter in 2018. This is largely attributable to reduced investment expenses. When comparing the three and nine months ended September 30, 2019 and 2018, income from investing activities was comparable in the majority of the investment categories, with the largest variance being found in the fixed maturities and short term investment categories.

Income from fixed maturities was down approximately 23% for the nine months ended September 30, 2019 when compared to the nine months ended September 30, 2018. In the third quarter of 2018, the Company sold a substantial bond holding. The bond holding was initially acquired over a period of time in 2016 at a deep discount, with an average cost of 25% of its par value. At the time of sale, management had determined the value of the security had recovered sufficiently enough and the time was right to sell a majority of the holding, realizing a gain of approximately $10 million. The proceeds from the sale were replaced with higher-rated, lower-yielding bonds.

During 2018, the Company held a short term note receivable that produced investment income of $331,898. The Company has not invested in any similar such short term investments during 2019 and is therefore not reporting any income from short term investments during the current year.

For the nine-months ended September 30, 2019, investment expenses were down approximately 49% when compared to the same period in 2018. The variance is due to a one-time fee bonus of $1.5 million paid as a result of the sale of certain discounted bonds in the third quarter of 2018.

In summary, the Company’s basis for future revenue growth is expected to come from the following primary sources: conservation of business currently in-force, the maximization of investment earnings and the acquisition of other companies or policy blocks in the life insurance business. Management has placed a significant emphasis on the development of these revenue sources to enhance these opportunities.

Expenses

The Company reported total benefits and other expenses of approximately $17.9 million for the nine months ended September 30, 2019, a decrease of approximately 10% from the same period in 2018. For the three month period ended September 30, 2019, total benefits and other expenses decreased approximately 18%, compared to the same quarter in 2018. Benefits, claims and settlement expenses represented approximately 65% and 64% of the Company’s total expenses for the three and nine months ended September 30, 2019, respectively. The other major expense category of the Company is operating expenses, which represented approximately 33% of the Company’s total expenses for the three and nine months ended September 30, 2019.

Life benefits, claims and settlement expenses, net of reinsurance benefits and claims, decreased approximately 4% in the nine months ended September 30, 2019, compared to the same period in 2018. For the three months ended September 30, 2019, life benefits, claims and settlement expenses, net of reinsurance benefits and claims, increased approximately 5%, compared to the same quarter in 2018. Policy claims vary from period to period and therefore, fluctuations in mortality are to be expected and are not considered unusual by Management.

Net amortization of cost of insurance acquired decreased 4% during the three and nine months ended September 30, 2019 compared to the same period in 2018. Cost of insurance acquired is established when an insurance company is acquired or when the Company acquires a block of in-force business. The Company assigns a portion of its cost to the right to receive future profits from insurance contracts existing at the date of the acquisition. Cost of insurance acquired is amortized with interest in relation to expected future profits, including direct charge-offs for any excess of the unamortized asset over the projected future profits. The interest rates may vary due to risk analysis performed at the time of acquisition on the business acquired. The Company utilizes a 12% discount rate on the remaining unamortized business. The amortization is adjusted retrospectively when estimates of current or future gross profits to be realized from a group of products are revised. Amortization of cost of insurance acquired is particularly sensitive to changes in interest rate spreads and persistency of certain blocks of insurance in-force. This expense is expected to decrease, unless the Company acquires a new block of business.

Operating expenses decreased approximately 43% for the three-month period ended September 30, 2019 compared to that of the same period in 2018. For the nine months ended September 30, 2019 operating expenses decreased approximately 19% compared to that of the same period in 2018. The variance is mainly attributable to a decrease in charitable contributions and salary expenses. Earnings in the prior year resulted in a higher accrual for salary expense in anticipation of annual performance bonuses for both management and staff. The significant realized gains from the sale of discounted bonds in third quarter 2018 was the primary driver of this variation.

Charitable contributions are a function of the Company’s earnings. UTG has a strong philanthropic program and the Company generally allocates a portion of its earnings to be sued for its philanthropic efforts primarily targeted to Christ-centered organizations or organizations that help the weak or poor. Charitable contributions made by the Company are expected to vary from year to year depending on the earnings of the Company.

Management continues to place significant emphasis on expense monitoring and cost containment. Maintaining administrative efficiencies directly impacts net income.

Financial Condition

Investment Information

Investments represent approximately 85% of total assets at September 30, 2019 and December 31, 2018. Accordingly, investments are the largest asset group of the Company. The Company's insurance subsidiary is regulated by insurance statutes and regulations as to the type of investments that it is permitted to make and the amount of funds that may be used for any one type of investment. In light of these statutes and regulations, the majority of the Company’s investment portfolio is invested in a diverse set of securities.

As of September 30, 2019, the carrying value of fixed maturity securities in default as to principal or interest was immaterial in the context of consolidated assets, shareholders’ equity or results from operations. To provide additional flexibility and liquidity, the Company has identified all fixed maturity securities as "investments available for sale". Investments available for sale are carried at market, with changes in market value charged directly to shareholders' equity. Changes in the market value of available for sale securities resulted in net unrealized gains of $2.5 million and $9.5 million for the three and nine months ended September 30, 2019, respectively. The variance in the net unrealized gains and losses is the result of normal market fluctuations and changes in interest rates.

Capital Resources

Total shareholders’ equity increased by approximately 20% as of September 30, 2019 compared to December 31, 2018. The increase in total shareholders’ equity is largely attributable to the net income reported for the period of $13.2 million and an increase of $9.5 million of accumulated other comprehensive income.

The Company’s investments are predominately in fixed maturity investments such as bonds. Changes in the current interest rate and The Company carries all of its fixed maturity holdings as available for sale, which are reported in the Condensed Consolidated Financial Statements at their market value.

Liquidity

The Company has two principal needs for cash - the insurance company’s contractual obligations to policyholders and the payment of operating expenses. Cash and cash equivalents represented 6% and 5% of total assets as of September 30, 2019 and December 31, 2018, respectively. Fixed maturities, as a percentage of total assets, were approximately 42% and 41% as of September 30, 2019 and December 31, 2018, respectively.

The Company currently has access to funds for operating liquidity. UTG has an $8,000,000 revolving credit note with Illinois National Bank. At September 30, 2019, the Company had no outstanding borrowings against the UTG line of credit. UG has a $10 million line of credit with the Federal Home Loan Bank. At September 30, 2019, the Company had no outstanding borrowings against the UG line of credit.

Future policy benefits are primarily long-term in nature and therefore, the Company's investments are predominantly in long-term fixed maturity investments such as bonds and mortgage loans which provide sufficient return to cover these obligations. Many of the Company's products contain surrender charges and other features which reward persistency and penalize the early withdrawal of funds.

Net cash used in operating activities was approximately $5.3 million for the nine months ended September 30, 2019 and approximately $1.8 million for the same period of 2018. Sources of operating cash flows of the Company, as with most insurance entities, is comprised primarily of premiums received on life insurance products and income earned on investments. Uses of operating cash flows consist primarily of payments of benefits to policyholders and beneficiaries and operating expenses. The Company has not marketed any significant new products for several years. As such, premium revenues continue to decline. Management anticipates future cash flows from operations to remain similar to historic trends.

Net cash provided by investing activities was approximately $12.3 million and $3 million for the nine months ended September 30, 2019 and 2018, respectively. The net cash provided by investing activities is expected to vary from quarter to quarter depending on market conditions and management’s ability to find and negotiate favorable investment contracts.

UTG is a holding Company that has no day-to-day operations of its own. Funds required to meet its expenses, generally costs associated with maintaining the Company in good standing with states in which it does business and the servicing of its debt, are primarily provided by its subsidiaries. On a parent only basis, UTG's cash flow is dependent on Management fees received from its insurance subsidiary, stockholder dividends from its subsidiary and earnings received on cash balances. At September 30, 2019, substantially all of the consolidated shareholders’ equity represented net assets of its subsidiary. The Company's insurance subsidiary has maintained adequate statutory capital and surplus. The payment of cash dividends to shareholders by UTG is not legally restricted. However, the state insurance department regulates insurance Company dividend payments where the Company is domiciled. No dividends were paid to shareholders in 2018 or the nine months ended September 30, 2019.

UG is an Ohio domiciled insurance company, which requires notification within five business days to the insurance commissioner following the declaration of any ordinary dividend and at least ten calendar days prior to payment of such dividend. Ordinary dividends are defined as the greater of: a) prior year statutory net income or b) 10% of statutory capital and surplus. For the year ended December 31, 2018, UG had statutory net income of approximately $6.2 million. At December 31, 2018 UG’s statutory capital and surplus amounted to approximately $60 million. Extraordinary dividends (amounts in excess of ordinary dividend limitations) require prior approval of the insurance commissioner and are not restricted to a specific calculation. During 2018, UG paid UTG ordinary dividends of $5 million. During the nine month period ended September 30, 2019, UG paid UTG dividends of $4.5 million. During October of 2019, UG paid UTG a dividend of $1.5 million. UTG used the dividends received during 2018 and 2019 to purchase outstanding shares of UTG stock and for general operations of the Company.

ITEM 4. CONTROLS AND PROCEDURES

The Company maintains a set of disclosure controls and procedures designed to ensure that information required to be disclosed in reports that it files or submits under the Securities Exchange Act of 1934, as amended (the Exchange Act), is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms. In addition, the disclosure controls and procedures ensure that information required to be disclosed is accumulated and communicated to Management, including the principal executive officer and principal financial officer, allowing timely decisions regarding required disclosure. Under the supervision and with the participation of our Management, including our principal executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Exchange Act. Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

NONE

ITEM 1A. RISK FACTORS

NONE

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

NONE

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

NONE

ITEM 4. MINE SAFETY DISCLOSURES

NONE

ITEM 5. OTHER INFORMATION

NONE

ITEM 6. EXHIBITS

*31.1	Certification of Jesse T. Correll, Chief Executive Officer and Chairman of the Board of UTG, as required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
*31.2	Certification of Theodore C. Miller, Chief Financial Officer, Senior Vice President and Corporate Secretary of UTG, as required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
*32.1	Certificate of Jesse T. Correll, Chief Executive Officer and Chairman of the Board of UTG, as required pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
*32.2	Certificate of Theodore C. Miller, Chief Financial Officer, Senior Vice President and Corporate Secretary of UTG, as required pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
**101	Interactive Data File

*Filed herewith

EXHIBIT INDEX

Exhibit Number	Description
*31.1	Certification of Jesse T. Correll, Chief Executive Officer and Chairman of the Board of UTG, as required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
*31.2	Certification of Theodore C. Miller, Chief Financial Officer, Senior Vice President and Corporate Secretary of UTG, as required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
*32.1	Certificate of Jesse T. Correll, Chief Executive Officer and Chairman of the Board of UTG, as required pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
*32.2	Certificate of Theodore C. Miller, Chief Financial Officer, Senior Vice President and Corporate Secretary of UTG, as required pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
**101	Interactive Data File

* Filed herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

UTG, INC.

(Registrant)

Date:	November 12, 2019	By	/s/ James P. Rousey
			James P. Rousey
			President and Director

Date:	November 12, 2019	By	/s/ Theodore C. Miller
			Theodore C. Miller
			Senior Vice President and Chief Financial Officer